Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002306945 | SCV002604041 | likely pathogenic | Deficiency of alpha-mannosidase | 2022-04-29 | criteria provided, single submitter | clinical testing | NM_000528.3(MAN2B1):c.2602_2612del11(Q868Gfs*59) is expected to be pathogenic in the context of alpha-mannosidosis. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in MAN2B1, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |